Support Without a Cancer Diagnosis: Helping People at Risk Find Comfort

Those with a genetic predisposition to cancer can benefit from support groups as much as cancer patients, but options for the former group are limited. One man highlights the divide.

7:00 AM

Author | Shelley Zalewski

Kevin Myers is neither a cancer patient nor a cancer survivor.

Yet, in his 59 years, hardly a day has passed that hasn't been affected by the disease.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Myers was born with a genetic predisposition to colon cancer. His condition, familial adenomatous polyposis, or FAP, is one of a number of inherited colon cancer syndromes — including Lynch syndrome and MYH-associated polyposis (MAP).

About 3 percent of colon cancers are associated with these genetic syndromes, says Elena Stoffel, M.D., director of the Cancer Genetics Clinic at the University of Michigan Comprehensive Cancer Center.

"In patients with FAP, polyps develop in the colon as soon as early adolescence, numbering in the hundreds or even thousands," Stoffel says. "Without treatment, their risk of developing cancer exceeds 90 percent."

The alternative for most patients is just as overwhelming: the removal of the colon and life with an ostomy pouch.

Myers' colon was removed at age 14. Learning to live with an ileostomy — an opening in the abdominal wall made during surgery that allows digestive content to exit the body though a stoma into a pouch — made his youth especially tough.

"Although I've never been diagnosed with it, you could say my whole life has been defined by cancer," Myers says.

Still, he persevered through high school, college and graduate school, where he trained in social work and counseling — and where he met and married Brenda, his wife of 34 years.

To avoid passing on the FAP gene, the Myers pursued in vitro fertilization, giving birth to their daughter in 1995.

Strength in numbers

People living with these genetic syndromes might often feel isolated and marginalized. Resources and support groups available to cancer patients typically do not exist for people at high risk of cancer.

SEE ALSO: Collecting a Family's Cancer History: What You Should Ask

This was Myers' reality until a self-described "lightbulb moment" more than two years ago.

As he recalls, "I had enrolled in a clinical trial at the cancer center. Speaking with the study coordinator, I wondered aloud if there was such a thing as a support group for people like me."

When he found no such support network, Myers decided to take up the challenge himself that same day. It took nearly a year, but he realized his dream in May 2014 when about 20 patients and family members joined him for the first educational group meeting for people living with hereditary syndromes.

On April 20, Myers' support group will mark its second anniversary at the Cancer Support Community of Greater Ann Arbor (reservations recommended; see below for more details). He has also learned of another hereditary colorectal cancer group starting in Grand Rapids, Michigan.

The ongoing effort mirrors the founder's outlook on life.

Says Myers: "I've grown from considering my condition a curse to seeing it as an opportunity to make lemonade out of lemons."

Tips for starting your own support network

Want to form your own group? Myers offered suggestions based on his experience:

Go online: Connect with patients on social media. See what group activities are offered in other communities and find out how they got started.

Use existing resources: Myers reached out to the Hereditary Colon Cancer Foundation in Park City, Utah, for guidance — as well as the University of Michigan Rogel Cancer Center (which connected him with Stoffel) and the Cancer Support Community of Greater Ann Arbor.

Be patient: Although it didn't happen overnight for Myers, the results were worth the work and wait. "Connecting with people who really understand feels like coming home," he says. "And knowing that my experience might help someone else has made it all worthwhile."

More Articles About: Cancer Care Cancer and Genetics Cancer Risk Factors Cancer Counseling Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories A family discussing their family's medical history at Thanksgiving
Health Lab
Why you need to discuss your family health history at Thanksgiving
The holidays are a great time to discuss your family's medical history. Learn the importance of discussing your family's health history & how to bring it up.
IV drip
Health Lab
Monitoring program flags cancer patients at risk of highly toxic chemotherapy side effects
Researchers from the University of Michigan Health Rogel Cancer Center have developed a monitoring system using a research genetics program to trigger alerts about cancer patients suspected to have the DPYD gene variant.
DNA helix technology robotic cybernetic image
Health Lab
Metabolite tells cells whether to repair DNA
Findings from researchers at the University of Michigan Health Rogel Cancer Center, published in Cancer Discovery, show how a specific nucleotide metabolite called GTP controls responses to radiation and chemotherapy in an unexpected way.
Doctors with patient while on exam table
Health Lab
Can personalized care prevent overscreening for colorectal cancer in older adults?
Study reveals presenting adults between 76 and 85 with personalized information about the benefits and harms of colon cancer screening decreases excess screening
cancer cell yellow blue
Health Lab
Potato starch supplements could be solution to bone marrow transplant complications
University of Michigan Health Rogel Cancer Center scientists have found a potential solution for preventing a common and dangerous complication in patients that receive stem cell transplants from a donor’s blood or bone marrow.  
older person pouring pills into hand close up
Health Lab
Early findings suggest this cancer drug may be effective against advanced tumors caused by genetic mutations
Sparrow Health System, part of University of Michigan Health, experts release findings in a study of a cancer drug for patients with genetic mutations.